Factors predicting clinical and endoscopic remission with placebo therapy in East Asian patients with ulcerative colitis: a systematic review and meta-analysis

[1] Fumery M(2018)Natural History of Adult Ulcerative Colitis in Population-based Cohorts: A Systematic Review Clin Gastroenterol Hepatol 16 343-356.e343

[2] Singh S(2018)Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies Lancet 390 2769-2778

[3] Dulai PS(2017)Incidence and Clinical Outcomes of Inflammatory Bowel Disease in South Korea, 2011–2014: A Nationwide Population-Based Study Dig Dis Sci 62 2102-2112

[4] Ng SC(2018)A Systematic Review of Epidemiology and Risk Factors Associated With Chinese Inflammatory Bowel Disease Front Med (Lausanne) 5 183-526

[5] Shi HY(2007)A meta-analysis of the placebo rates of remission and response in clinical trials of active ulcerative colitis Gastroenterology 132 516-625

[6] Hamidi N(2019)Psychobiological Mechanisms of Placebo and Nocebo Effects: Pathways to Improve Treatments and Reduce Side Effects Annu Rev Psychol 70 599-618

[7] Jung YS(2016)Systematic Review and Meta-analysis: Placebo Rates in Induction and Maintenance Trials of Ulcerative Colitis J Crohns Colitis 10 607-1596

[8] Han M(2018)Systematic review with meta-analysis: endoscopic and histologic placebo rates in induction and maintenance trials of ulcerative colitis Aliment Pharmacol Ther 47 1578-11537

[9] Kim WH(2014)Clinical characteristics and treatment of inflammatory bowel disease: a comparison of Eastern and Western perspectives World J Gastroenterol 20 11525-180

[10] Park S(2015)Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement Syst Rev 4 1-188

[1] Fumery M(2018)Natural History of Adult Ulcerative Colitis in Population-based Cohorts: A Systematic Review Clin Gastroenterol Hepatol 16 343-356.e343

[2] Singh S(2018)Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies Lancet 390 2769-2778

[3] Dulai PS(2017)Incidence and Clinical Outcomes of Inflammatory Bowel Disease in South Korea, 2011–2014: A Nationwide Population-Based Study Dig Dis Sci 62 2102-2112

[4] Ng SC(2018)A Systematic Review of Epidemiology and Risk Factors Associated With Chinese Inflammatory Bowel Disease Front Med (Lausanne) 5 183-526

[5] Shi HY(2007)A meta-analysis of the placebo rates of remission and response in clinical trials of active ulcerative colitis Gastroenterology 132 516-625

[6] Hamidi N(2019)Psychobiological Mechanisms of Placebo and Nocebo Effects: Pathways to Improve Treatments and Reduce Side Effects Annu Rev Psychol 70 599-618

[7] Jung YS(2016)Systematic Review and Meta-analysis: Placebo Rates in Induction and Maintenance Trials of Ulcerative Colitis J Crohns Colitis 10 607-1596

[8] Han M(2018)Systematic review with meta-analysis: endoscopic and histologic placebo rates in induction and maintenance trials of ulcerative colitis Aliment Pharmacol Ther 47 1578-11537

[9] Kim WH(2014)Clinical characteristics and treatment of inflammatory bowel disease: a comparison of Eastern and Western perspectives World J Gastroenterol 20 11525-180

[10] Park S(2015)Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement Syst Rev 4 1-188